You are seeing these quotes based on previous browsing related to sectors such as
| Latest | Forecast | |
|---|---|---|
| Div Yield | 1.2% | 1.2% |
| Div Cover | 8.6 | 9.1 |
| Op Mrgn | 8.3% | 23.1% |
| ROCE | 29.0% |
| Latest | Forecast | |
|---|---|---|
| P/E | 9.3 | 9.8 |
| PEG | 0.5 | 0.6 |
| Price / Revenue | 1.6 | 1.7 |
| Price / Book value | 1.8 |
| Latest | Forecast | |
|---|---|---|
| Revenue | 10.4% | 0.0% |
| PBT | 83.7% | n/a |
| EPS | 20.6% | 0.0% |
| DPS | 13.6% | 0.0% |
| Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 2016-06-30 | 339.90 | 15.90 | 33.40p | 18.1 | 0.9 | 19% | 4.00p | 0.7% |
| 2017-06-30 | 302.30 | 14.10 | 41.30p | 20.8 | 0.9 | 24% | 5.00p | 0.6% |
| 2018-06-30 | 381.20 | 35.90 | 45.40p | 20.2 | 2.0 | 10% | 5.60p | 0.6% |
| 2019-06-30 | 456.90 | 12.30 | 54.40p | 18.5 | 0.9 | 20% | 6.70p | 0.7% |
| 2020-06-30 | 504.30 | 22.60 | 65.60p | 12.4 | 0.6 | 21% | 7.61p | 0.9% |
| Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 2021-06-30 | 538.16 | 102.70 | 64.66p | 10.2 | -7.1 | -1% | 8.01p | 1.2% |
| Thursday broker round-up Sharecast News | 23 Jul |
|---|---|
| Clinigen FY revenues continue to rise, profit growth slowed by Covid-19 Sharecast News | 14 Jul |
| Clinigen gets orphan drug designation for 'aldesleukin' in the US Sharecast News | 13 Jul |
| Final Results | 17-Sep-20 07:05 |
|---|---|
| Board changes | 16-Sep-20 09:01 |
| Notice of Results | 27-Aug-20 12:01 |
| Year end trading update | 14-Jul-20 07:04 |
| Aldesleukin: Orphan Drug Designation in ALS by FDA | 13-Jul-20 07:03 |